| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
| Products Intro: |
Product Name:CCR5 antagonist 1
CAS:716354-86-8
Purity:98% Package:5mg；10mg；20mg；50mg；100mg；200mg
|
|
| | CCR5 antagonist 1 Basic information |
| Product Name: | CCR5 antagonist 1 | | Synonyms: | CCR5 antagonist 1;Benzenesulfonamide, 4-chloro-N-(1,1-dimethylethyl)-2-fluoro-5-[[4-(3-fluorophenyl)-4-[2-[(3-endo)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl]-1-piperidinyl]carbonyl]-;CCR-5 antagonist 1,CCR5 antagonist 1 | | CAS: | 716354-86-8 | | MF: | C39H46ClF2N5O3S | | MW: | 738.34 | | EINECS: | | | Product Categories: | | | Mol File: | 716354-86-8.mol |  |
| | CCR5 antagonist 1 Chemical Properties |
| Boiling point | 849.9±75.0 °C(Predicted) | | density | 1.36±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 11.10±0.50(Predicted) |
| | CCR5 antagonist 1 Usage And Synthesis |
| Description | CCR5 antagonist 1 is a CCR5 antagonist which can inhibit HIV replication extracted from WO 2004054974 A2. | | References | [1]. Wieslaw Mieczyslaw Kazmierski, et al. Piperidine derivatives as ccr5 antagonists. WO 2004054974 A2. |
| | CCR5 antagonist 1 Preparation Products And Raw materials |
|